Wockhardt informs about press release

21 Jan 2019 Evaluate

Wockhardt has informed about submission of proposed Press Release titled ‘Wockhardt Receives US FDA Approval for Leukemia drug’.

The above information is a part of company’s filings submitted to BSE.

Wockhardt Share Price

1176.90 -9.75 (-0.82%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×